You searched for united kingdom - Page 48 of 55

News and Trends 26 Aug 2022

Beyond Biotech podcast 11: Ilya Pharma, IRB Barcelona, Krystal Biotech, Phase Genomics

…to start a clinical trial for cystic fibrosis after the United States Food and Drug Administration (FDA) accepted its investigational new drug (IND) application. The gene therapy company will be…

August 26, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 10 Nov 2022

Parthenon and ImaginAb enter into license and supply agreement for anti-cancer therapies

…its investigational CD8 ImmunoPET technology to Parthenon Therapeutics for use in the clinical development of PRTH-101 at clinical trial sites across the United States. Initially, Parthenon Therapeutics will investigate CD8…

November 10, 2022 - 4 minutesmins - By Liza Laws

News and Trends 23 Mar 2017

A Cheaper Heat-Stable Vaccine Could Prevent Child Deaths in Africa

…III trial that has ever been done in Niger, and it will be probably be the first vaccine that is pre-qualified [for United Nations subsidies] out of the cold chain,”…

March 23, 2017 - 3 minutesmins - By Melanie De Almeida

News and Trends 2 Jul 2020

Freeline Closes €106M Series C to Progress Hemophilia Gene Therapy

…closing of the Series C round, Freeline also stated that “it expects to consider additional capital raising options this year, which could include an initial public offering in the United…

July 2, 2020 - 3 minutesmins - By Helen Albert

News and Trends 5 Oct 2022

FDA fast tracks Immutep non-small cell lung cancer candidate

Immutep Limited says the United States Food and Drug Administration (FDA) has granted fast track designation to eftilagimod alpha (efti or IMP321) in combination with pembrolizumab for the treatment of…

October 5, 2022 - 3 minutesmins - By Jim Cornall

Best in Biotech 10 Jun 2025

Pushing biotech forward in France: 18 companies to know about

…heart function by 25%, without observed side effects. The company plans to initiate first-in-human studies of PLG-101 in 2025 across Europe and the United States. To support this, Polygon secured…

June 10, 2025 - 16 minutesmins - By Jules Adam

News and Trends 10 Nov 2022

SOTIO reveal potential treatment for adults with solid tumors at SITC meeting

…total of approximately 320 patients with a maximum of 50 to 57 per indication in Europe and the United States. SOTIO entered into a clinical trial collaboration and supply agreement…

November 10, 2022 - 4 minutesmins - By Liza Laws

News and Trends 20 Apr 2017

Goodbye Glybera! The World’s First Gene Therapy will be Withdrawn

…not go for the renewal of its marketing authorization for Glybera in Europe, which is set to expire in October this year. Since Glybera missed approval in the United States,…

April 20, 2017 - 3 minutesmins - By Evelyn Warner

In Depth 27 Jun 2025

Psychedelics sans side effects: neuroplastogens gain ground

…Convention last week, was recently issued a ‘Notice of Allowance’ for its new class of neuroplastogens called aminated tryptamine derivatives by the United States Patent and Trademark Office (USPTO). This…

June 27, 2025 - 8 minutesmins - By Roohi Mariam Peter

More News! 7 Nov 2022

Sensorion granted rare pediatric disease designation by FDA for lead therapy gene

…congenital hearing loss, around 20,000 people are affected in the United States and in Europe. Sensorion has progressed preclinical and clinical development plans for OTOF-GT and is on track to…

November 7, 2022 - 2 minutesmins - By Liza Laws

In Depth 12 Jul 2017

Genomic Testing in Oncology: From Single Genes to Whole Genomes

…for Molecular Pathology v. Myriad Genetics“ challenged the validity of gene patents in the United States, specifically patents owned by Myriad Genetics that covered human DNA sequences, including BRCA. Since…

July 12, 2017 - 5 minutesmins - By Timothé Cynober

Merck, drug development, lab work, lab worker, scientist

Top Reasons to Outsource Your Early Clinical Pipeline to a CDMO

…free guidebook to navigate through the important considerations necessary to successfully bring a molecule to the clinic. *The Life Science business of Merck operates as MilliporeSigma in the United States…

January 26, 2022 - 8 minutesmins - By Sudha Sundaram

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: united kingdom

Beyond Biotech podcast 11: Ilya Pharma, IRB Barcelona, Krystal Biotech, Phase Genomics

Parthenon and ImaginAb enter into license and supply agreement for anti-cancer therapies

A Cheaper Heat-Stable Vaccine Could Prevent Child Deaths in Africa

Freeline Closes €106M Series C to Progress Hemophilia Gene Therapy

FDA fast tracks Immutep non-small cell lung cancer candidate

Pushing biotech forward in France: 18 companies to know about

SOTIO reveal potential treatment for adults with solid tumors at SITC meeting

Goodbye Glybera! The World’s First Gene Therapy will be Withdrawn

Psychedelics sans side effects: neuroplastogens gain ground

Sensorion granted rare pediatric disease designation by FDA for lead therapy gene

Genomic Testing in Oncology: From Single Genes to Whole Genomes

Top Reasons to Outsource Your Early Clinical Pipeline to a CDMO

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!